BrainsWay Ltd. reported $41M of revenue over the trailing twelve months, +29% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $41M (to FY2024). Net income: $2.9M, trailing twelve months to FY2024. Free cash flow: −$1.4M, trailing twelve months to FY2021. Operating margin: 3.4%, trailing twelve months to FY2024.

BWAYBrainsWay Ltd.

Healthcare

$11.44+50% 1Y

$11.44

$7.2552 weeks$17.17

BWAY as reported

BrainsWay Ltd. reported $41M of revenue over the trailing twelve months, +29% on the year before. 9 reported series are charted on this page, each one as filed.

$41M

Revenue, trailing twelve months · to FY2024 · +29% against the twelve months before

Net income: $2.9M
Net income · −170% year on year · trailing twelve months to FY2024
Free cash flow: −$1.4M
Free cash flow · trailing twelve months to FY2021
Operating margin: 3.4%
Operating margin · trailing twelve months to FY2024

Details›

Every series Ryufin has for BWAY, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$41M	+29%	FY2024
Net income	$2.9M	−170%	FY2024
EPS	$0.05	−138%	FY2024
Gross margin	75%	n/a	FY2024
Operating margin	3.4%	n/a	FY2024
Net margin	7.1%	n/a	FY2024
ROE	4.7%	n/a	FY2024
ROA	3.1%	n/a	FY2024
Free cash flow	−$1.4M	n/a	FY2021

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.